AnalystsAndrew GallerAndrew Galler's Stock Forecasts
AnalystsAndrew Galler
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4446 out of 4870 analysts
Average Return
-15.15%
Win Rate
28%5 out of 18
Risk vs Reward
Poor
Good
Andrew Galler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vir Biotechnology IncVIR | +65.86% | $25.66 | $8.76 | 2022-11-03 - 2023-11-03 | Strong Sell |
Vir Biotechnology IncVIR | +50.85% | $22.38 | $11.00 | 2022-09-08 - 2023-09-08 | Strong Sell |
Immunocore Holdings PLCIMCR | +24.83% | $44.75 | $55.86 | 2022-09-08 - 2023-09-08 | Strong Buy |
Ionis Pharmaceuticals IncIONS | +4.05% | $45.47 | $47.31 | 2022-11-09 - 2023-11-09 | Strong Buy |
Immunocore Holdings PLCIMCR | +0.10% | $48.25 | $48.30 | 2022-10-12 - 2023-10-12 | Strong Buy |
Andrew Galler Analyst Color
Get additional color on Andrew Galler's coverage of popular stocks
Andrew Galler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunocore Holdings PLCIMCR | 13 | Hold | $35.00 | +16.09% | Assumes | 2 months ago |
Amicus Therapeutics IncFOLD | 5 | Hold | $15.00 | N/A | Maintains | a year ago |
Silence Therapeutics PLCSLN | 1 | Hold | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Hold | $37.00 | N/A | Maintains | 2 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $56.00 | N/A | Maintains | 2 years ago |
Vir Biotechnology IncVIR | 2 | Strong Sell | $18.00 | N/A | Maintains | 2 years ago |
Ptc Therapeutics IncPTCT | 1 | Hold | $54.00 | N/A | Initiates Coverage On | 3 years ago |
Halozyme Therapeutics IncHALO | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Adc Therapeutics SaADCT | 1 | Buy | $44.00 | N/A | Initiates Coverage On | 3 years ago |
Moderna IncMRNA | 1 | Buy | $304.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.